Publication | Open Access
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales
92
Citations
25
References
2020
Year
Ceftazidime-avibactam may be a valuable therapeutic option for serious infections due to GNB other than CRE.
| Year | Citations | |
|---|---|---|
Page 1
Page 1